TAGLN co‐distributed with GSC markers CD133, CD15, SOX2, and OLIG2 in glioma cells (Figure 2E; Figure S2G, Supporting Information), suggesting that TAGLN was preferentially expressed in GSCs in patient tissues. The gene discussed is PROM1; the disease is central nervous system cancer.